The MAPK pathway across different malignancies: a new perspective.
作者： Mauricio Burotto , Victoria L. Chiou , Jung-Min Lee , Elise C. Kohn
DOI: 10.1002/CNCR.28864
关键词: MAPK/ERK pathway 、 Medicine 、 Cell biology 、 Melanoma 、 Mitogen-activated protein kinase kinase 、 Kinase 、 Protein kinase B 、 Proto-Oncogene Proteins B-raf 、 Cancer research 、 Cancer 、 Protein kinase A
摘要: … There are 4 independent MAPK pathways composed of 4 signaling families: the MAPK/ERK family or classical pathway and the Big MAP kinase-1 (BMK-1), c-Jun N-terminal kinase (…
sci-hub.se 参考文章(99)
Rachel N. Grisham, Gopa Iyer, Karuna Garg, Deborah DeLair, David M. Hyman, Qin Zhou, Alexia Iasonos, Michael F. Berger, Fanny Dao, David R. Spriggs, Douglas A. Levine, Carol Aghajanian, David B. Solit, BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer. Cancer. ,vol. 119, pp. 548- 554 ,(2013) , 10.1002/CNCR.27782
Ralf-Steffen Schmid, Wendy M Pruitt, Patricia F Maness, None, A MAP Kinase-Signaling Pathway Mediates Neurite Outgrowth on L1 and Requires Src-Dependent Endocytosis The Journal of Neuroscience. ,vol. 20, pp. 4177- 4188 ,(2000) , 10.1523/JNEUROSCI.20-11-04177.2000
Ie-Ming Shih, Robert J. Kurman, Ovarian Tumorigenesis : A Proposed Model Based on Morphological and Molecular Genetic Analysis American Journal of Pathology. ,vol. 164, pp. 1511- 1518 ,(2004) , 10.1016/S0002-9440(10)63708-X
Gideon Bollag, Peter Hirth, James Tsai, Jiazhong Zhang, Prabha N. Ibrahim, Hanna Cho, Wayne Spevak, Chao Zhang, Ying Zhang, Gaston Habets, Elizabeth A. Burton, Bernice Wong, Garson Tsang, Brian L. West, Ben Powell, Rafe Shellooe, Adhirai Marimuthu, Hoa Nguyen, Kam Y. J. Zhang, Dean R. Artis, Joseph Schlessinger, Fei Su, Brian Higgins, Raman Iyer, Kurt D’Andrea, Astrid Koehler, Michael Stumm, Paul S. Lin, Richard J. Lee, Joseph Grippo, Igor Puzanov, Kevin B. Kim, Antoni Ribas, Grant A. McArthur, Jeffrey A. Sosman, Paul B. Chapman, Keith T. Flaherty, Xiaowei Xu, Katherine L. Nathanson, Keith Nolop, Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF -mutant melanoma Nature. ,vol. 467, pp. 596- 599 ,(2010) , 10.1038/NATURE09454
N Dhanasekaran, E Premkumar Reddy, Signaling by dual specificity kinases Oncogene. ,vol. 17, pp. 1447- 1455 ,(1998) , 10.1038/SJ.ONC.1202251
X. Deschenes-Simard, M.-F. Gaumont-Leclerc, V. Bourdeau, F. Lessard, O. Moiseeva, V. Forest, S. Igelmann, F. A. Mallette, M. K. Saba-El-Leil, S. Meloche, F. Saad, A.-M. Mes-Masson, G. Ferbeyre, Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation Genes & Development. ,vol. 27, pp. 900- 915 ,(2013) , 10.1101/GAD.203984.112
L. V. Sequist, B. A. Waltman, D. Dias-Santagata, S. Digumarthy, A. B. Turke, P. Fidias, K. Bergethon, A. T. Shaw, S. Gettinger, A. K. Cosper, S. Akhavanfard, R. S. Heist, J. Temel, J. G. Christensen, J. C. Wain, T. J. Lynch, K. Vernovsky, E. J. Mark, M. Lanuti, A. J. Iafrate, M. Mino-Kenudson, J. A. Engelman, Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors Science Translational Medicine. ,vol. 3, ,(2011) , 10.1126/SCITRANSLMED.3002003
Alexa B. Turke, Kreshnik Zejnullahu, Yi-Long Wu, Youngchul Song, Dora Dias-Santagata, Eugene Lifshits, Luca Toschi, Andrew Rogers, Tony Mok, Lecia Sequist, Neal I. Lindeman, Carly Murphy, Sara Akhavanfard, Beow Y. Yeap, Yun Xiao, Marzia Capelletti, A. John Iafrate, Charles Lee, James G. Christensen, Jeffrey A. Engelman, Pasi A. Jänne, Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC Cancer Cell. ,vol. 17, pp. 77- 88 ,(2010) , 10.1016/J.CCR.2009.11.022
Inna V. Fedorenko, Kim H.T. Paraiso, Keiran S.M. Smalley, Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma. Biochemical Pharmacology. ,vol. 82, pp. 201- 209 ,(2011) , 10.1016/J.BCP.2011.05.015
Philippe L. Bedard, Aaron R. Hansen, Mark J. Ratain, Lillian L. Siu, Tumour heterogeneity in the clinic Nature. ,vol. 501, pp. 355- 364 ,(2013) , 10.1038/NATURE12627